Early stage niche Leverage Akeso’s focus on Fe3C compounds and silk biomaterial collaboration to position as a supplier of novel antimicrobial solutions for poultry farms, food processing facilities, and wound care clinics seeking alternatives to traditional antibiotics.

Campylobacter market Target food safety and animal health buyers by highlighting the lead product aimed at reducing Campylobacter in poultry, addressing a high-cost, high-impact pathogen with notable EU and US economic burdens.

Strategic partnerships Explore co-development, licensing, or exclusive supply arrangements with poultry producers, contract manufacturers, and biomaterials firms to accelerate adoption and reduce development risk for Fe3C-based products.

Financing signals Capitalize on recent financing activity and board appointments to approach potential investors and strategic partners with a clear growth thesis around pipeline expansion, regulatory milestones, and commercialization timelines.

Technical readiness Position Akeso’s silk biomaterial platform and broad-spectrum Fe3C activity as differentiators in biosafety, biofilm disruption, and wound care, targeting distributors and integrators serving biotech labs, veterinary suppliers, and medical device manufacturers.